These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 14527019)

  • 21. The CONRAD approach to biokinetic modeling of DTPA decorporation therapy.
    Breustedt B; Blanchardon E; Bérard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
    Health Phys; 2010 Oct; 99(4):547-52. PubMed ID: 20838097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative decorporation efficacy of 3,4,3-LIHOPO, 4,4,4-LIHOPO and DTPA after contamination of rats with soluble forms of 238Pu and 233U.
    Ramounet-Le Gall B; Grillon G; Rateau G; Burgada R; Bailly T; Fritsch P
    Radiat Prot Dosimetry; 2003; 105(1-4):535-8. PubMed ID: 14527023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of a system of models for plutonium decorporation therapy.
    Dumit S; Avtandilashvili M; McComish SL; Strom DJ; Tabatadze G; Tolmachev SY
    Radiat Environ Biophys; 2019 May; 58(2):227-235. PubMed ID: 30627772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of DTPA Treatment on Internal Dose Estimates.
    Davesne E; Blanchardon E; Peleau B; Correze P; Bohand S; Franck D
    Health Phys; 2016 Jun; 110(6):551-7. PubMed ID: 27115221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
    Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
    Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Four-decade follow-up of a plutonium-contaminated puncture wound treated with Ca-DTPA.
    Avtandilashvili M; Tolmachev SY
    J Radiol Prot; 2021 Nov; 41(4):. PubMed ID: 34034246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of plutonium and americium in the body 5 years after an exposure via contaminated punctured wound.
    Lagerquist CR; Hammond SE; Hyltron DB
    Health Phys; 1972 Jun; 22(6):921-4. PubMed ID: 5084028
    [No Abstract]   [Full Text] [Related]  

  • 28. Case study: three acute 241Am inhalation exposures with DTPA therapy.
    Carbaugh EH; Lynch TP; Cannon CN; Lewis LL
    Health Phys; 2010 Oct; 99(4):539-46. PubMed ID: 20838096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of DFO-HOPO, DTPA-DX and DTPA for enhancing the excretion of plutonium and ameriicum from the rat.
    Stradling GN; Gray SA; Moody JC; Hodgson A; Raymond KN; Durbin PW; Rodgers SJ; White DL; Turowski PN
    Int J Radiat Biol; 1991 May; 59(5):1269-77. PubMed ID: 1675243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biokinetic model analysis with DTPA administration for a case of accidental inhalation of actinides in Japan.
    Tani K; Ishigure N; Kim E; Tominaga T; Tatsuzaki H; Akashi M; Kurihara O
    Radiat Prot Dosimetry; 2023 Oct; 199(15-16):2025-2029. PubMed ID: 37819312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacies of 3,4,3-LIHOPO and DTPA for enhancing the excretion of plutonium and americium from the rat: comparison with other siderophore analogues.
    Stradling GN; Gray SA; Ellender M; Moody JC; Hodgson A; Pearce M; Wilson I; Burgada R; Bailly T; Leroux YG
    Int J Radiat Biol; 1992 Oct; 62(4):487-97. PubMed ID: 1357063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Actinide handling after wound entry with local or systemic decorporation therapy in the rat.
    Griffiths NM; Coudert S; Renault D; Wilk JC; Van der Meeren A
    Int J Radiat Biol; 2014 Nov; 90(11):989-95. PubMed ID: 24456546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pu and Am decorporation in beagles: effects of magnitude of initial Ca-DTPA injection upon chelation efficacy.
    Lloyd RD; Jones CW; Taylor GN; Mays CW; Atherton DR
    Radiat Res; 1979 Sep; 79(3):630-34. PubMed ID: 113846
    [No Abstract]   [Full Text] [Related]  

  • 34. Calcium and zinc DTPA administration for internal contamination with plutonium-238 and americium-241.
    Kazzi ZN; Heyl A; Ruprecht J
    Curr Pharm Biotechnol; 2012 Aug; 13(10):1957-63. PubMed ID: 22352730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AN ACCIDENT OF INTERNAL CONTAMINATION WITH PLUTONIUM AND AMERICIUM AT A NUCLEAR FACILITY IN JAPAN: A PRELIMINARY REPORT AND THE POSSIBILITY OF DTPA ADMINISTRATION ADDING TO THE DIAGNOSIS.
    Tatsuzaki H; Tominaga T; Kim E; Watanabe S; Tsutsumi Y; Sagara M; Takada C; Momose T; Kurihara O; Akashi M
    Radiat Prot Dosimetry; 2018 Dec; 182(1):98-103. PubMed ID: 30165696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferential decorporation of americium by pulmonary administration of DTPA dry powder after inhalation of aged PuO(2) containing americium in rats.
    Grémy O; Tsapis N; Chau Q; Renault D; Abram MC; Van der Meeren A
    Radiat Res; 2010 Nov; 174(5):637-44. PubMed ID: 20726717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three plutonium chelation cases at Los Alamos National Laboratory.
    Bertelli L; Waters TL; Miller G; Gadd MS; Eaton MC; Guilmette RA
    Health Phys; 2010 Oct; 99(4):532-8. PubMed ID: 20838095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined drug and surgery treatment of plutonium-contaminated wounds: indications obtained using a rodent model.
    Griffiths NM; Coudert S; Wilk JC; Renault D; Angulo JF; Van der Meeren A
    Health Phys; 2014 Jun; 106(6):638-44. PubMed ID: 24776894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ustur Case 0846: Modeling Americium Biokinetics after Intensive Decorporation Therapy.
    Breustedt B; Avtandilashvili M; McComish SL; Tolmachev SY
    Health Phys; 2019 Aug; 117(2):168-178. PubMed ID: 30489383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chelation Modeling: The Use of Ad Hoc Models and Approaches to Overcome a Dose Assessment Challenge.
    Dumit S; Bertelli L; Klumpp JA; Poudel D; Waters TL
    Health Phys; 2020 Feb; 118(2):193-205. PubMed ID: 31833972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.